TS
CYAD

Thomas Steyer’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Thomas Steyer’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,000
Closed -$1.56M – 100
2015
Q2 		$1.56M Buy
+30,000
New +$1.61M 0.02% 90

Other funds holding CYAD

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Thomas Steyer's CYAD Position: Q3 2015 in Review

Thomas Steyer sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q3 2015, closing a stake of 30,000 shares — an estimated $1.56M sold.

Thomas Steyer first reported a position in CYAD in Q2 2015 and held it in 1 quarter. The position peaked at $1.56M in Q2 2015. 10 funds tracked by Wall St. Rank hold CYAD as of Q3 2015.

  • Thomas Steyer reported no remaining Celyad Oncology SA American Depositary Shares position as of Q3 2015 after selling out during the quarter.
  • Thomas Steyer sold 30,000 Celyad Oncology SA American Depositary Shares shares in Q3 2015, an estimated $1.56M.
  • Thomas Steyer first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and held it in 1 quarter.
  • Thomas Steyer's Celyad Oncology SA American Depositary Shares position peaked at $1.56M in Q2 2015.
  • 10 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q3 2015.

Based on Farallon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.